Home › Funds › SECTOR GAMMA AS › PTCT
SECTOR GAMMA AS position in PTCT
PTC THERAPEUTICS INC · Health Care
SECTOR GAMMA AS reported holding 112,000 shares of PTCT (PTC THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.3M, representing 1.50% of its reported portfolio and ranking #28 among its reported holdings. SECTOR GAMMA AS has disclosed PTCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SECTOR GAMMA AS's PTCT position evolved
SECTOR GAMMA AS first disclosed a stake in PTCT in Q4 2024 at 65,250 shares (US$2.9M). The position peaked in Q2 2026 at 100,000 shares, worth US$8.2M. Across 8 filings, SECTOR GAMMA AS increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 112,000 shares valued at US$7.3M — an increase of 12,000 shares quarter over quarter.. Notable position changes include a 41% increase in Q1 2025 (shares fell 4% over the following quarter), a 48% trim in Q4 2025 (shares fell 10% over the following quarter), a 33% increase in Q2 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 65.25K | $2.95M | New |
| Q1 2025 | 92.25K | $4.70M | Add |
| Q2 2025 | 92.25K | $4.51M | Hold |
| Q3 2025 | 118.11K | $7.25M | Add |
| Q4 2025 | 61.92K | $4.70M | Reduce |
| Q1 2026 | 75.00K | $5.11M | Add |
| Q2 2026 | 100.00K | $8.16M | Add |
| Q3 2026 | 112.00K | $7.26M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PTCT and 13F data
PTCT (PTC THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in PTCT — the largest reported positions include RTW INVESTMENTS, LP (US$631.9M), TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$174.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PTCT
- RTW INVESTMENTS, LP 7.75M sh · $631.88M · Q2 2026
- TORONTO DOMINION BANK 2.17M sh · $176.67M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 2.70M sh · $174.86M · Q3 2026
- Hood River Capital Management LLC 1.74M sh · $141.82M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.44M sh · $117.47M · Q2 2026
- Blue Sparrow, LLC /DE 1.05M sh · $85.71M · Q2 2026
- Palo Alto Investors LP 918.85K sh · $74.95M · Q2 2026
- ARMISTICE CAPITAL, LLC 660.00K sh · $53.84M · Q2 2026
More on SECTOR GAMMA AS
FAQ
How long has SECTOR GAMMA AS held PTCT?
SECTOR GAMMA AS has disclosed PTCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is SECTOR GAMMA AS's current position in PTCT?
As of Q3 2026, SECTOR GAMMA AS holds 112.00K shares of PTCT (PTC THERAPEUTICS INC), valued at $7.26M, representing 1.50% of its reported portfolio and ranking #28.
Has SECTOR GAMMA AS been buying or selling PTCT?
In the latest 13F filing (Q3 2026), SECTOR GAMMA AS increased its position in PTCT. The position peaked in Q2 2026 at 100.00K shares.
Which other funds hold PTCT?
Other major institutional holders of PTCT include RTW INVESTMENTS, LP, TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.